Ethic Inc’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q1
Sell
-20,029
Closed -$277K 749
2021
Q4
$277K Buy
+20,029
New +$277K 0.02% 546